$59.58 +0.60 (%) Merck & Co Inc - NYSE

Dec. 19, 2014 | 04:00 PM

Partner Headlines

  1. Tetraphase Jumps As 'Superbug' Drug Scores In Trial

    IBD | Dec. 18, 2014 | 11:54AM EST
  2. Druckenmiller Adds Healthcare Stocks to Portfolio

    GuruFocus | Dec. 15, 2014 | 16:57PM EST
  3. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD | Dec. 11, 2014 | 14:25PM EST
  4. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga | Dec. 11, 2014 | 14:14PM EST
  5. Celgene's Abraxane Succeeds In Early Breast Cancer

    IBD | Dec. 11, 2014 | 11:27AM EST
  6. Merck repurposes cancer drug

    IBD | Dec. 10, 2014 | 18:43PM EST
  7. Merck's Keytruda Might Treat Virulent Breast Cancer

    IBD | Dec. 10, 2014 | 11:04AM EST
  8. Data Investigating KEYTRUDA, Merck's Anti-PD-1 Therapy, In Patients With Advanced Triple-Negative Breast Cancer Presented At 2014 San Antonio Breast Cancer Symposium

    Benzinga | Dec. 10, 2014 | 08:34AM EST
  9. Merck-Cubist deal going ahead

    IBD | Dec. 9, 2014 | 18:42PM EST
  10. Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO

    Benzinga | Dec. 9, 2014 | 15:02PM EST
  11. Mizuho Securities Downgrades Cubist Pharmaceuticals Post Acquisition Announcement

    Benzinga | Dec. 9, 2014 | 12:14PM EST
  12. Merck-Cubist Deal Going Ahead Despite Patent Setback

    IBD | Dec. 9, 2014 | 11:27AM EST
  13. Hospira, Inc. Ticks Up On Favorable Patent Ruling vs. Cubist Pharmaceuticals Inc

    Benzinga | Dec. 9, 2014 | 11:09AM EST
  14. Pharmaceutical Giant Merck Buys Cubist Pharma

    GuruFocus | Dec. 9, 2014 | 11:04AM EST
  15. Stocks Swoon In Heavy Trade; Spirit Airlines Spirals Lower

    IBD | Dec. 9, 2014 | 10:38AM EST
  16. T Rowe Price's Top Stakes for the Third Quarter

    GuruFocus | Dec. 9, 2014 | 10:16AM EST
  17. Merck & Co. Under Pressure Following Patent Ruling

    Benzinga | Dec. 9, 2014 | 09:30AM EST
  18. Cellceutix Corp Shares Rise On Two Catalysts

    Benzinga | Dec. 9, 2014 | 09:28AM EST
  19. Merck Bets $9.5 Billion On Cubist's War On Superbugs

    IBD | Dec. 8, 2014 | 18:49PM EST
  20. Merck Buys Super Antibiotics

    IBD | Dec. 8, 2014 | 18:47PM EST
  21. Energy Leads Stock Sell-Off

    IBD | Dec. 8, 2014 | 18:47PM EST
  22. Benzinga's M&A Chatter for Monday December 8, 2014

    Benzinga | Dec. 8, 2014 | 18:27PM EST
  23. Making Money With Charles Payne: 12/8/14

    FoxBusiness | Dec. 8, 2014 | 18:00PM EST
  24. 3 Biotech ETFs Rally On Merger News

    Benzinga | Dec. 8, 2014 | 17:43PM EST
  25. Mid-Afternoon Market Update: Dow Slides Over 100 Points; Oil Futures Down 4%

    Benzinga | Dec. 8, 2014 | 15:37PM EST
  26. Stocks Fall To Session Lows: GoPro Gives Up More Ground

    IBD | Dec. 8, 2014 | 13:25PM EST
  27. Mid-Day Market Update: McDonald's Drops On Weak November Sales; Acceleron Pharma Shares Jump

    Benzinga | Dec. 8, 2014 | 12:56PM EST
  28. Merck's CEO Doesn't Think That Valuations In The Biotech Industry Are 'Rich'

    Benzinga | Dec. 8, 2014 | 12:46PM EST
  29. Merck Acquiring Cubist, Focusing On Hospital Care

    IBD | Dec. 8, 2014 | 11:48AM EST
  30. Mid-Morning Market Update: Markets Mixed; Merck To Buy Cubist Pharmaceuticals For $102/Share

    Benzinga | Dec. 8, 2014 | 10:46AM EST
  31. Benzinga's Volume Movers

    Benzinga | Dec. 8, 2014 | 10:20AM EST
  32. Stocks Hitting 52-Week Highs

    Benzinga | Dec. 8, 2014 | 10:08AM EST
  33. Morning Market Movers

    Benzinga | Dec. 8, 2014 | 09:44AM EST
  34. Merck Aims at Superbugs with $9.5B Cubist Buy

    FoxBusiness | Dec. 8, 2014 | 09:42AM EST
  35. Pharmaceutical Stocks In Play Following Merck/Cubist Deal

    Benzinga | Dec. 8, 2014 | 09:09AM EST
  36. Stocks Set For Weak Start; Cubist Leaps On Buyout

    IBD | Dec. 8, 2014 | 08:48AM EST
  37. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 8, 2014 | 08:11AM EST
  38. US Stock Futures Point To Lower Open Monday

    Benzinga | Dec. 8, 2014 | 07:01AM EST
  39. Must Watch Stocks for December 8, 2014

    Benzinga | Dec. 8, 2014 | 04:32AM EST
  40. Benzinga's Weekend M&A Chatter

    Benzinga | Dec. 7, 2014 | 18:24PM EST
  41. Merck in Talks to Acquire Cubist for ~$100/Share

    Benzinga | Dec. 5, 2014 | 23:24PM EST
  42. 5 Stock-Moving Medtech Events This December

    IBD | Nov. 28, 2014 | 14:18PM EST
  43. You Should Hold Merck According to Dividends Generation

    GuruFocus | Nov. 21, 2014 | 13:47PM EST
  44. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD | Nov. 20, 2014 | 11:44AM EST
  45. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  46. Merck's Vytorin Works: Study

    IBD | Nov. 17, 2014 | 18:39PM EST
  47. Incyte Building Blockbuster Drug One Disease At A Time

    IBD | Nov. 17, 2014 | 15:58PM EST
  48. Merck Drug Works: Vytorin Study Proves Successful

    IBD | Nov. 17, 2014 | 13:35PM EST
  49. Merck Announces That IMPROVE-IT Achieved Primary Endpoint; Data To Be Presented At American Heart Association Scientific Sessions Today

    Benzinga | Nov. 17, 2014 | 08:31AM EST
  50. Gilead Sciences Releases Impressive Results for Hepatitis C Drug

    GuruFocus | Nov. 12, 2014 | 11:56AM EST
Trading Center